Haematology clinical trials

Our Haematology Clinical Research Unit is the largest clinical trial site of its kind in Australia. Established in 2009, it is now our largest clinical trial unit, with up to 100 clinical trials running at any one time. We specialise in the treatment of blood cancers and disorders, and have expertise in Phase I and first-in-human trials of novel therapies.

male clinical trials patient in bed with a male nurse standing nearby with a syringe

Why are clinical trials so important?

We need clinical trials to prove that a new medication, device or treatment is safe and effective for people.

Without clinical trials, new treatments and medicines cannot be approved for use in Australia.

Find out more about clinical trials

About us

Our haematology clinical trials started in the early 1990s with a leukaemia trial. The Haematology Clinical Research Unit (CRU) was established in 2009 and is now our largest clinical trial unit, with up to 100 clinical trials running at any one time.

We specialise in the treatment of blood cancers and disorders. We have particular expertise in Phase I and first-in-human trials of novel therapies.

Find out more about our statewide clinical haematology services.
 

What are Phase I, II, III or IV clinical trials?

There are four different phases of a clinical trial. Each phase is represented by a roman numeral.

Find out more about what happens in each phase
Patient getting blood taken

Our vision

  • Provide the most effective, personalised treatment to patients with blood cancers and disorders by integrating high quality, cutting-edge and patient-focused clinical trial research into everyday practice

Our focus

We provide Phase I, II, III and IV clinical trials across these blood cancers:

  • Multiple myeloma
  • Acute myeloid leukaemia (AML)
  • Acute lymphocytic leukaemia (ALL)
  • Chronic lymphocytic leukaemia
  • Myelofibrosis
  • Myelodysplastic syndrome
  • Lymphomas

We also conduct clinical trials in treatments for haematological disorders such as:

  • Haemophilia
  • Aplastic anaemia
  • Clotting disorders
  • Autoimmune haemolytic anaemia
Left to Right, The Hon. Darren Chester MP, Australian Government representative and local MP, Alfred Health’s Director of Research Professor Stephen Jane, Director of TrialHub Anne Woollett, and Latrobe Regional Hospital’s Chief Executive Officer Pete

Our achievements

  • Partnering with TrialHub to provide patients in regional and remote hospitals access to cancer clinical trials. Currently supporting the first ever myeloma clinical trial open for recruitment at Latrobe Regional Hospital
  • Victoria’s only adult haemophilia treatment centre in a public hospital. Currently conducting a number of gene therapy and pain management clinical trials
  • One of only two Victorian hospitals conducting Car-T Cell clinical trials, a new form of immunotherapy that uses some of the patient’s own altered immune cells to fight blood cancer

Our team

The Alfred Haematology Clinical Trials team are leaders in their fields, with decades of Australian and international experience:

  • Prof Andrew Spencer, Malignant Haematology, Transplantation and Cellular Therapies and Head of Myeloma Research
  • Prof Huyen Tran, Head Thrombosis & Haemostasis Unit
  • Prof Andrew Perkins, Head of Genomic Medicine
ClinTrial Refer website

Are you interested in our clinical trials?

ClinTrial Refer is a quick way to see all of our open trials, in one place. It’s the easy way to find a trial that may be right for you or your patient.

Find Haematology clinical trials clinical trials on ClinTrial Refer

Our partners